CNTA
Centessa Pharmaceuticals
CNTA
CNTA
44 hedge funds and large institutions have $258M invested in Centessa Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
Holders
44
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$9.74M | |
| 2 | +$6.53M | |
| 3 | +$1.99M | |
| 4 |
Morgan Stanley
New York
|
+$1.65M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
+$1.52M |
Top Sellers
| 1 | -$6.58M | |
| 2 | -$4.39M | |
| 3 | -$474K | |
| 4 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$341K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$284K |